Search

ALL PSYCHEDELIC AND PSYCHEDELIC STOCK NEWS

Amanita Muscaria in a Vape!

Featured Editor | Curator -
Vaping amanita mushrooms? You heard it right! The new Happy Daze Amanita Muscaria...
View Post

Interview: Dr. Deborah Nash, Ibogaine and Miami Based DemeRX.

INTERVIEW Editor | Curator -
Partnered with ATAI Life Sciences ATAI. Amazing Interview. "I said there's no way that you can take one dose of Ibogaine...
View Post

Psychedelic Marketing Tips: Adrian Morrison

INTERVIEW Editor | Curator -
The Absolute Champion of Internet Advertising, Adrian Morrison, makes a believer out of Jordan, which is saying everything! Why can’t this be...
View Post

Shark Tank’s Kevin Harrington Invests In Psychedelics Company Psycheceutical (BWVI). Forbes

2023 Watch List Editor | Curator -
Mike Zapolin, Kevein Harrington and CEO Chad Harman Another Shark Tank original has invested in the psychedelic industry.
View Post

Adding Psycheceutical Bioscience (BWVI) $0.14 to Watch List. (Ketamine.)

2023 Watch List Editor | Curator -
Above: Lamar Odom and Psychedelic Advocate Mike Zappy Zapolin. We’re Calling a Sector Bottom, and Psycheceutical (BWVI)...
View Post

Ketamine and Yale University

INTERVIEW Editor | Curator -
Depression is one of the most common and most debilitating mental health disorders, affecting some 17 million adults in the US. It...
View Post

Johns Hopkins Receives $20M From Roland R. Griffiths Ph.D. Professorship Fund For Psychedelic Research

CLINICAL TRIALS Editor | Curator -
John Hopkins Center for Psychedelic and Consciousness Research Johns Hopkins University academics just a got a boost in their funding thanks to...
View Post

Is ATAI Live Sciences (ATAI) $2.00, Finally Turning?

2023 Watch List Editor | Curator -
After Dropping 94% From Post IPO high from $19.45, a loss of exceeding $3 billion and change, ATAI is in the early...
View Post

PSYCHECEUTICAL TO CONDUCT THE FIRST EVER PHASE I AND II CLINICAL TRIALS OF A NOVEL KETAMINE TOPICAL CREAM TO TREAT PTSD

INTERVIEW Editor | Curator -
Psycheceutical ​​enters into agreement with iNGENū to conduct ​human ​clinical trials of NeuroDirect™ ketamine topical ​in Australia
View Post

The Kahner Global Cannabis & Psychedelics Investment Summit.

PSYCH NEWS Editor | Curator -
Kahner Global’s 8th annual Cannabis & Psychedelics Investment Summit  When:...
View Post

Awakn Life Sciences (AWKNF) $0.30 Announces Signing of Lease for Second Clinic in Norway.

CLINICS Editor | Curator -
Trondheim in central Norway will be the location of Awakn's 4th clinic LIVE QUOTE
View Post

Silo Pharma (SILO) Issues Letter to Shareholders

2023 Watch List Editor | Curator -
Silo Pharma Issues Letter to Shareholders Detailing Progress on Pipeline Assets Combining Traditional Therapeutics with Psychedelic Medicine LIVE QUOTE
View Post

Silo Pharma (SILO) $3.36 Achieves New Milestone for SP-26 Therapeutic -Initiates IND Enabling Study of Topical Ketamine Formulation

Featured Editor | Curator -
View Post ENGLEWOOD CLIFFS, NJ, Nov. 11, 2022 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“the Company”), a developmental stage...
View Post
1234...11Page 3 of 11

KetaDash

Ketamine at Home Treatments
RESEARCH

Most Popular

Compass Pathways (CMPS) Gets a Beat Down. Adding to 2025 Watch List, $2.36

Featured Editor | Curator -
The Montgomery-Asberg Depression Rating Scale. We were flying from Hawaii to Las Vegas yesterday and when we landed,...

Interview: MAPS Founder Rick Doblin and Clearmind Medicine (CMND) CEO, Adi Zuloff-Shani.

2024 WATCH LIST Editor | Curator -
INTRO VIDEO https://youtu.be/-RQikn6O3qw?si=o_IBy9yTlmfNNvky Join Clearmind Medicine CEO, Adi Zuloff-Shani,...

1000 Days Without Alcohol: Here’s What Happened

ALCOHOL Editor | Curator -
No..we didn't give up drinking - at least not yet. But we RUMinate about it from time to time. At a dinner...

LARGE CAP PSYCHEDELIC STOCKS

PSYCHEDELIC FUNDS AND ETFS

Copyright Revelers,io Media for Instiutional Analyst Inc.